CLL-027 Tolerability and Outcomes of Oral Targeted Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01253-9
M
Micaela R. Scobie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
36
Citations
3
h-index
2
i10-index
Micaela R. Scobie is an academic researcher from Precision for Medicine (United States). The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Lung Cancer Treatments and Mutations & Chronic Myeloid Leukemia Treatments. The author has an h-index of 3, co-authored 17 publications.
ORCID: 0000-0002-9217-0562Papers by this author
worksTolerability and Outcomes of Oral Targeted Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)00559-7
62539 Evaluating the Impact of Travel Distance on Melanoma Care for North Carolina Veterans: No Significant Differences between Rural and Urban Settings
2025 · Journal of the American Academy of Dermatology · 0 citations
https://doi.org/10.1016/j.jaad.2025.05.790
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat